← All companies

IMNM

Immunome, Inc.

IMNM Nasdaq Pharmaceutical Preparations EDGAR ↗

$23.01

+0.25 +1.10%

Key statistics

from XBRL data in SEC filings

Market cap

$2.61B

Revenue (TTM)

$4.01M

Net income (TTM)

-$225M

EPS (TTM)

$-2.39

P/E ratio

—

Dividend yield

—

Free cash flow

-$201M

Cash

$583M

Total assets

$620M

Gross margin

—

52-week range

$8.67 – $27.65

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Shareholder vote results Jun 12, 2026 10-Q Quarter ended 2026-03-31 May 12, 2026 8-K Results of operations (earnings release) May 12, 2026 10-K Fiscal year ended 2025-12-31 Mar 3, 2026 8-K Results of operations (earnings release) Mar 3, 2026 8-K Other events Dec 17, 2025 8-K Regulation FD disclosure; Other events Dec 15, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 10-Q Quarter ended 2025-06-30 Aug 6, 2025 8-K Results of operations (earnings release) Aug 6, 2025 8-K Shareholder vote results Jun 11, 2025 10-Q Quarter ended 2025-03-31 May 12, 2025 8-K Results of operations (earnings release); Other events May 12, 2025 10-K Fiscal year ended 2024-12-31 Mar 19, 2025 8-K Results of operations (earnings release) Mar 19, 2025 8-K Other events Jan 30, 2025 8-K Results of operations (earnings release); Other events Jan 29, 2025 8-K Director or officer change Jan 23, 2025 10-Q Quarter ended 2024-09-30 Nov 13, 2024 8-K Results of operations (earnings release) Nov 13, 2024 8-K Entered a material agreement; Terminated a material agreement; Completed an acquisition or disposition; Unregistered sale of equity Oct 29, 2024 8-K Other events Oct 8, 2024 10-Q Quarter ended 2024-06-30 Aug 12, 2024 8-K Results of operations (earnings release) Aug 12, 2024 8-K Shareholder vote results Jun 13, 2024 10-Q Quarter ended 2024-03-31 May 14, 2024 8-K Results of operations (earnings release) May 14, 2024 8-K Director or officer change Apr 30, 2024 8-K Director or officer change Apr 25, 2024 10-K Fiscal year ended 2023-12-31 Mar 28, 2024 8-K Results of operations (earnings release) Mar 28, 2024 8-K Entered a material agreement; Completed an acquisition or disposition; Unregistered sale of equity; Regulation FD disclosure Mar 26, 2024 8-K Other events Feb 14, 2024 8-K Results of operations (earnings release); Other events Feb 13, 2024 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Feb 6, 2024 8-K Director or officer change Feb 1, 2024 8-K Regulation FD disclosure Jan 11, 2024 8-K Entered a material agreement; Unregistered sale of equity Jan 8, 2024 8-K Director or officer change Jan 2, 2024